Friday, February 7, 2020

In the News: Letting Pharmacists Provide Naloxone Without Prescription Leads to Surge in Access



Center on Addiction
Partnership for Drug-Free Kids
NEWS
Top Drug & Alcohol News of the Week
narcan naloxone nasal spray
 
Letting Pharmacists Provide Naloxone Without Prescription Leads to Surge in Access
Allowing pharmacists in Ohio to provide the opioid overdose antidote naloxone without a prescription led to a more than 2,000% increase in dispensing of the drug, a new study finds. Read More
ShareTweet
teen vaping e-cigarettes
New E-Cigarette Ban Loophole Allows Teens to Switch to Disposable Devices
The new Food and Drug Administration ban on most flavored e-cigarettes contains a loophole that allows teens to use disposable devices, The New York Times reports.
Read More
ShareTweet
 
doctor and patient
40% of U.S. Counties Have No Providers Approved to Prescribe Buprenorphine
A new government report finds 40% of U.S. counties didn’t have a single healthcare provider approved to prescribe the opioid addiction medication buprenorphine in 2018. Read More
ShareTweet
Help Us Continue to Empower Families:
 

E-Cigarette CEOs Face Questions From House Panel on Youth Marketing
E-cigarette company executives faced questions this week from a congressional committee on their role in the teen vaping epidemic, ABC News reports. Read More
ShareTweet
Newly Discovered Cannabis Compound Could be 30 Times More Potent Than THC
Scientists have discovered a cannabis compound that could be 30 times more potent than THC, the psychoactive ingredient in marijuana, CNN reports. Read More
ShareTweet
Other Headlines of Interest
Partnership for Drug-Free Kids and Center on Addiction have merged. Learn More
PARENT HELPLINE

CALL 1-855-DRUGFREE

TEXT A MESSAGE TO 55753

VISIT DRUGFREE.ORG
Center on Addiction  Partnership for Drug-Free Kids
Facebook  Twitter  YouTube  Instagram  LinkedIn
© Partnership for Drug-Free Kids
Center on Addiction
633 Third Ave | 19th Floor
New York, NY 10017-6706
Privacy Policy | 

No comments:

Post a Comment